Jyesha Isis Wren, CNM, WHNP, RN Nurse Practitioner - Women's Health Medicare: Medicare Enrolled Practice Location: 2721 Comstock Cir, Belmont, CA 94002 Phone: 831-713-6602 |
Ms. Bertha Dolores Saucedo, PNP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 2005 Lyon Ave, Belmont, CA 94002 Phone: 605-301-4573 |
Ms. Christina Thuy Tran, L. AC., F.N.P. Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 950 Ralston Ave, Belmont, CA 94002 Phone: 415-822-9999 |
Lynda Ann Mackin, NP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 1301 Shoreway Rd, Suite 100, Belmont, CA 94002 Phone: 650-596-7000 Fax: 650-596-7093 |
Ms. Patricia Mary Wieser, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1541 Harbor Blvd, Belmont, CA 94002 Phone: 650-595-2400 |
Dr. Oksana Prodan, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1301 Shoreway Rd Ste 100, Belmont, CA 94002 Phone: 650-596-7000 Fax: 650-596-7093 |
News Archive
To solve a puzzle, you need to recognize shapes, patterns and a particular kind of order. In much the same way, researchers at McGill University have discovered that the 3D shape of a leukemia cell's genome holds a key to solving the puzzle of human diseases. The researchers report their findings in the open access journal Genome Biology.
DNAnexus, Inc., a leading provider of cloud-based solutions for analyzing, visualizing, and managing next-generation sequencing data, today announced the availability of a comprehensive set of new informatics tools that enable life science researchers to efficiently analyze and manage large-scale genomic variation datasets in a cloud-based workflow.
Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
The Global Fund to Fight AIDS, Tuberculosis and Malaria Board of Directors on Wednesday approved 79 grants with a two-year commitment of "$1.7 billion dollars for projects against the diseases, amid warnings that some hard-hit African countries were being left out," Agence France-Presse reports. The commitment, according to Ethiopian Health Minister Tedros Adhanom Ghebreyesus, who chairs the Global Fund's board, "shows that even in hard economic times, we can continue to expand the fight against the three diseases" (12/15).
› Verified 1 days ago